Effect of Prophylactic Application of 40Hz Transcranial Stimulation in AICU on Incidence of Postoperative Delirium in Elderly Patients Undergoing Elective Gastrointestinal Surgery

October 24, 2024 updated by: Henan Provincial People's Hospital
Postoperative delirium is an acute central nervous system dysfunction caused by surgical stress, which is manifested by postoperative acute, non-specific changes in consciousness level, attention, cognitive ability and disturbance of sleep and wake cycles. It is one of the most common surgical complications in the elderly, occurring in more than 75% of patients receiving mechanical ventilation in the intensive care unit(ICU).Exogenous 40 Hz stimulation can improve cognitive functioning.Therefore, the aim of this study was to investigate the effect of exogenous 40Hz stimulation on the incidence of postoperative delirium in elderly patients undergoing elective gastrointestinal surgery in AICU.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

98

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Zhang jiaqiang
  • Phone Number: 037165580728
  • Email: hnmzxh@163.com

Study Locations

    • Henan
      • Zhengzhou, Henan, China
        • Recruiting
        • Henan People's Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 1.Age ≥ 65 years old,gender not limited
  • 2.ASA classification Ⅱ ~ Ⅳ
  • 3.Elective gastrointestinal general anesthesia surgery

Exclusion Criteria:

  • 1.History of schizophrenia, epilepsy, Parkinson's disease, or myasthenia gravis
  • 2.Pre-operative coma, severe dementia, speech impairment or severe illness incapacitated and unable to communicate
  • 3.Delirium on admission or pre-operative delirium, brain injury
  • 4.Severely infected person
  • 5.Severe liver dysfunction (Child-Pugh C), severe renal insufficiency (preoperative dialysis)
  • 6.Severe hearing or vision impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
After admission to AICU, the control group was not stimulated at 40Hz ;
Experimental: 40Hz stimulation group
After admission to AICU, the experimental group was stimulated at 40Hz for 6h;
Exogenous 40HZ stimulation is a physical intervention that can drive oscillations in the gamma range, and the oscillations and pulses caused at the corresponding frequency can lead to a significant reduction in β-amyloid, reverse tau hyperphosphorylation, and thereby improve the cognitive function of patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence of postoperative delirium
Time Frame: Day 1, Day 2, Day 3 ,Day 4, Day 5, Day 6,Day 7 after surgery
Postoperative delirium was assessed using the CAM-ICU scale.The RASS score (The Richmond Agitation-Sedation Scale) was used to assess arousal. When the patient's RASS score is not -4 /-5, delirium evaluation can continue considering the patient's wakefulness status.CAM-ICU scale contains four features (Feature 1, Feature 2, Feature 3, and Feature 4). Delirium can be diagnosed when the patient is positive for features 1, 2, 3, or 4.
Day 1, Day 2, Day 3 ,Day 4, Day 5, Day 6,Day 7 after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood Markers
Time Frame: half hour, 6hours, 24hours and 48hours after transfer to aicu
Serum Tau proteomic analysis and CRP, IL-6, and TNF-ɑ were recorded
half hour, 6hours, 24hours and 48hours after transfer to aicu
Sleep quality
Time Frame: 8:00 to 10:00 every morning for the first three days after surgery
The Chinese version of the Richards-Campbell Sleep Quality Scale Score (RCSQ) was used to evaluate sleep quality. RCSQ scoring average for five projects, including 0 ~ 25 points on behalf of the poor quality of sleep, on behalf of the sleep quality of 76 ~ 100 points; The higher the score says sleep quality, the better
8:00 to 10:00 every morning for the first three days after surgery
The incidence of pain
Time Frame: 6hours, 24hours, 48hours after surgery
Mark a 0-10cm horizontal line on the paper with a ruler, and determine the score in millimeters (mm). The score range is 0-100mm, and the higher the score, the greater the pain intensity; No pain (0-4 mm), mild pain (5-44 mm), moderate pain (45-74 mm), severe pain (75-100 mm).
6hours, 24hours, 48hours after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2024

Primary Completion (Estimated)

March 1, 2025

Study Completion (Estimated)

March 1, 2025

Study Registration Dates

First Submitted

July 23, 2024

First Submitted That Met QC Criteria

August 3, 2024

First Posted (Actual)

August 7, 2024

Study Record Updates

Last Update Posted (Actual)

October 28, 2024

Last Update Submitted That Met QC Criteria

October 24, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Delirium

Clinical Trials on 40Hz stimulation

Subscribe